Showing posts with label truvada. Show all posts
Showing posts with label truvada. Show all posts

Tuesday 22 September 2015

Doctors Recommend A New Drug For The Prevention Of HIV Infection

Doctors Recommend A New Drug For The Prevention Of HIV Infection.
Should rank and file in hazard of contracting HIV because they have risky sex filch a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of contemplation on this question, a new international study suggests the medication doesn't lead occupy to stop using condoms or have more sex with more people. The research isn't definitive, and it hasn't changed the opinion of every expert. But one of the study's co-authors said the findings support the drug's use as a disposition to prevent infection with HIV, the virus that causes AIDS.

And "People may have more partners or stop using condoms, but as well as we can tell, it's not because of taking the analgesic to prevent HIV infection ," said study co-author Dr Robert Grant, a superior investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in inquiry is called Truvada, which combines the drugs emtricitabine and tenofovir. It's normally utilized to treat people who are infected with HIV, but research - in many-coloured and bisexual men and in straight couples with one infected partner - have shown that it can lower the risk of infection in multitude who become exposed to the virus through sex.

However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the painkiller for prevention purposes in 2012. Few people seem to be taking it for balk purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 people are taking the drug for that mind in the United States. In the new study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.

The exploration participants, who all faced hilarious risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an sluggish placebo. Those who believed they were taking Truvada "were just as uninjured as everyone else," Grant said, suggesting that they weren't more favoured to stop using condoms or be more promiscuous because they believed they had extra charge against HIV infection.